Novel 3-(1H-indol-3-yl)-2-[3-(4-methoxyphenyl)ureido]- propanamides as selective agonists of human formyl-peptide receptor 2; Bioorganic & Medicinal Chemistry; Vol. 23, Iss. 14

Podrobná bibliografie
Parent link:Bioorganic & Medicinal Chemistry
Vol. 23, Iss. 14.— 2015.— [P. 3913–3924]
Korporativní autor: Национальный исследовательский Томский политехнический университет (ТПУ) Институт физики высоких технологий (ИФВТ) Кафедра биотехнологии и органической химии (БИОХ)
Další autoři: Lacivita E. Enza, Schepetkin (Shchepyotkin) I. A. Igor Aleksandrovich, Madia L. Stama, Kirpotina L. N. Liliya Nikolaevna, Colabufo N. A. Nicola, Perrone R. Roberto, Khlebnikov A. I. Andrey Ivanovich, Quinn M. T. Mark, Leopoldo M. Marcello
Shrnutí:Title screen
N-Formyl peptide receptors (FPRs) are G protein-coupled receptors (GPCRs) that play critical roles in inflammatory reactions, and FPR-specific interactions can possibly be used to facilitate the resolution of pathological inflammatory reactions. We here report the synthesis and biological evaluation of six pairs of chiral ureidopropanamido derivatives as potent and selective formyl peptide receptor-2 (FPR2) agonists that were designed starting from our lead agonist (S)-3-(1H-indol-3-yl)-2-[3-(4-methoxyphenyl)ureido]-N-[[1-(5-methoxy-2-pyridinyl)cyclohexyl]methyl]propanamide ((S)-9a). The new compounds were obtained in overall yields considerably higher than (S)-9a. Several of the new compounds showed agonist properties comparable to that of (S)-9a along with higher selectivity over FPR1. Molecular modeling was used to define chiral recognition by FPR2. In vitro metabolic stability of selected compounds was also assessed to obtain preliminary insight on drug-like properties of this class of compounds.
Режим доступа: по договору с организацией-держателем ресурса
Jazyk:angličtina
Vydáno: 2015
Témata:
On-line přístup:http://dx.doi.org/10.1016/j.bmc.2014.12.007
Médium: MixedMaterials Elektronický zdroj Kapitola
KOHA link:https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=644681

MARC

LEADER 00000nla0a2200000 4500
001 644681
005 20250317135923.0
035 |a (RuTPU)RU\TPU\network\9765 
035 |a RU\TPU\network\5164 
090 |a 644681 
100 |a 20151126d2015 k||y0rusy50 ba 
101 0 |a eng 
102 |a NL 
135 |a drcn ---uucaa 
181 0 |a i  
182 0 |a b 
200 1 |a Novel 3-(1H-indol-3-yl)-2-[3-(4-methoxyphenyl)ureido]- propanamides as selective agonists of human formyl-peptide receptor 2  |f E. Lacivita, I. A. Schepetkin (Shchepyotkin), Madia L. Stama [et al.] 
203 |a Text  |c electronic 
300 |a Title screen 
320 |a [References: p. 3923-3924 (40 tit.)] 
330 |a N-Formyl peptide receptors (FPRs) are G protein-coupled receptors (GPCRs) that play critical roles in inflammatory reactions, and FPR-specific interactions can possibly be used to facilitate the resolution of pathological inflammatory reactions. We here report the synthesis and biological evaluation of six pairs of chiral ureidopropanamido derivatives as potent and selective formyl peptide receptor-2 (FPR2) agonists that were designed starting from our lead agonist (S)-3-(1H-indol-3-yl)-2-[3-(4-methoxyphenyl)ureido]-N-[[1-(5-methoxy-2-pyridinyl)cyclohexyl]methyl]propanamide ((S)-9a). The new compounds were obtained in overall yields considerably higher than (S)-9a. Several of the new compounds showed agonist properties comparable to that of (S)-9a along with higher selectivity over FPR1. Molecular modeling was used to define chiral recognition by FPR2. In vitro metabolic stability of selected compounds was also assessed to obtain preliminary insight on drug-like properties of this class of compounds. 
333 |a Режим доступа: по договору с организацией-держателем ресурса 
461 |t Bioorganic & Medicinal Chemistry 
463 |t Vol. 23, Iss. 14  |v [P. 3913–3924]  |d 2015 
610 1 |a электронный ресурс 
610 1 |a труды учёных ТПУ 
610 1 |a метаболические процессы 
701 1 |a Lacivita  |b E.  |g Enza 
701 1 |a Schepetkin (Shchepyotkin)  |b I. A.  |c doctor-biophysicist  |c leading researcher of Tomsk Polytechnic University, candidate of medical science  |f 1962-  |g Igor Aleksandrovich  |3 (RuTPU)RU\TPU\pers\37358 
701 0 |a Madia L. Stama 
701 1 |a Kirpotina  |b L. N.  |g Liliya Nikolaevna 
701 1 |a Colabufo  |b N. A.  |g Nicola 
701 1 |a Perrone  |b R.  |g Roberto 
701 1 |a Khlebnikov  |b A. I.  |c Chemist  |c Professor of Tomsk Polytechnic University  |f 1963-  |g Andrey Ivanovich  |3 (RuTPU)RU\TPU\pers\33927  |9 17500 
701 1 |a Quinn  |b M. T.  |g Mark 
701 1 |a Leopoldo  |b M.  |g Marcello 
712 0 2 |a Национальный исследовательский Томский политехнический университет (ТПУ)  |b Институт физики высоких технологий (ИФВТ)  |b Кафедра биотехнологии и органической химии (БИОХ)  |3 (RuTPU)RU\TPU\col\18693 
801 2 |a RU  |b 63413507  |c 20201103  |g RCR 
856 4 |u http://dx.doi.org/10.1016/j.bmc.2014.12.007 
942 |c CF